Short versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols in IVF/ICSI Cycles in Patients of Various Age Ranges

被引:15
|
作者
Ou, Jianping [1 ]
Xing, Weijie [1 ]
Li, Yubin [2 ]
Xu, Yanwen [2 ]
Zhou, Canquan [2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 07期
关键词
IN-VITRO FERTILIZATION; POOR RESPONDERS; EMBRYO QUALITY; AGONIST; STIMULATION; INDUCTION; OVULATION; IVF;
D O I
10.1371/journal.pone.0133887
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective To compare the two GnRH-a protocols (long GnRH-a protocol and short GnRH-a protocol) for ovarian stimulation in IVF/ICSI cycles in patients of various age ranges. Methods A total of 5662 IVF-ET/ICSI cycles from 2010 to 2013 were retrospectively identified. The cycles were divided into two groups: a long protocol group and short protocol group. In each group, the patients were divided into four age ranges: <31 years, 31 to 35 years, 36 to 40 years, and >40 years. The duration of stimulation, total dose of Gn, implantation rate and pregnancy rate were compared. Results The total dose of Gn was significantly higher, and the duration of stimulation was significantly longer, in the long protocol group than in the short protocol group for all age ranges (P<0.05). If the patients were of the same age range, the number of oocytes retrieved, MII oocytes, and high-quality embryos in the long protocol group were all significantly greater than those in the short protocol group (P<0.05). In the long protocol group, the clinical pregnancy rates of the four age ranges were 52.76%, 44.33%, 36.15% and 13.33%, respectively, which were significantly higher than those in the short protocol group (33.33%, 24.58%, 22.49% and 8.72%, respectively; P<0.05). The same trend was also found in the implantation rates of the four age ranges. As the age increased, the clinical pregnancy and implantation rates, as well as the number of oocytes retrieved, MII oocytes, and high-quality embryos, of the long protocol group significantly decreased (P<0.05). Conclusions Our study demonstrated that regardless of patient age, the long protocol was superior to the short protocol in terms of the number of retrieved oocytes, as well as the implantation and pregnancy rates.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG) in normal responder patients undergoing IVF/ICSI cycles: a retrospective analysis
    Luque, L.
    Castillo, J. C.
    Guerrero, J.
    Gomez-Santana, J.
    Llacer, J.
    Bernabeu, R.
    HUMAN REPRODUCTION, 2015, 30 : 306 - 306
  • [12] Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone
    Rösler, A
    Witztum, E
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07): : 416 - 422
  • [13] Is the long-acting gonadotropin-releasing hormone agonist long protocol better for patients with endometriosis undergoing IVF?
    Wang, Xiuzhu
    Li, Wenshu
    Chen, Xuemei
    Zhang, Wei
    Chu, Min
    Yin, Shuyuan
    Chu, Yongli
    Liu, Xuemei
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 162 (01) : 325 - 332
  • [14] SUPPRESSION WITH GONADOTROPIN-RELEASING HORMONE ANALOGS PRIOR TO STIMULATION WITH GONADOTROPINS - COMPARISON OF 3 PROTOCOLS
    LIPITZ, S
    BENRAFAEL, Z
    DOR, J
    SHALEV, J
    ELENBOGEN, A
    LEVRAN, D
    SERR, DM
    MASHIACH, S
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1989, 28 (01) : 31 - 34
  • [15] Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surge in hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI Cycles
    Tandulwadkar, Sunita
    Gupta, Shruti
    Singh, Akhileshwar
    Mishra, Sneha
    Singhania, Samta
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2023, 27 (01): : 15 - 19
  • [16] Short- and long-term impact of gonadotropin-releasing hormone analogue treatment on bone loss and fracture
    Sauerbrun-Cutler, May-Tal
    Alvero, Ruben
    FERTILITY AND STERILITY, 2019, 112 (05) : 799 - 803
  • [17] Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism
    Tng, Eng-Loon
    Tan, Jeanne May May
    JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (01) : 1 - 13
  • [18] Gonadotropin-Releasing Hormone Agonist Versus Recombinant Human Chorionic Gonadotropin Triggering in Fertility Preservation Cycles
    Herzberger, Einat Haikin
    Knaneh, Sabaa
    Amir, Hadar
    Reches, Adi
    Ben-Yosef, Dalit
    Kalma, Yael
    Azem, Foad
    Samara, Nivin
    REPRODUCTIVE SCIENCES, 2021, 28 (12) : 3390 - 3396
  • [19] Corifollitropin alfa is safe and efficacious in IVF patients undergoing repeated gonadotropin-releasing hormone antagonist ovarian stimulation cycles
    Rombauts, L.
    Heijnen, E.
    Marintcheva-Petrova, M.
    Elbers, J.
    HUMAN REPRODUCTION, 2010, 25 : I242 - I243
  • [20] Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates
    Cramer, DW
    Powers, DR
    Oskowitz, SP
    Liberman, RF
    Hornstein, MD
    McShane, PM
    Barbieri, RL
    FERTILITY AND STERILITY, 1999, 72 (01) : 83 - 89